CRISPR-Cas9

Gabriele Casagrande Raffi1, Hendrik J Kuiken2, Cor Lieftink2

  • 1Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Nature protocols
|October 8, 2025
PubMed
概括

这项研究引入了针对非增殖细胞的新CRISPR查协议. 可诱导的Cas9系统能够在衰老等状态下进行精确的基因编辑,有助于发现新的治疗点.